South Dakota Representative Opposes Expansion of Federal 340B Drug Pricing Program

South Dakota's Representative Dusty Johnson argues against expanding the federal 340B Drug Pricing Program despite its goal of improving rural healthcare access. He contends that the current expansion would be detrimental rather than beneficial for the state's communities. This stance reflects broader conservative concerns about federal overreach in healthcare pricing and distribution.